10 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp.
21 Mar 24
Annual report
8:51pm
, reputational harm, administrative burdens, diminished profits and future earnings, additional reporting requirements and/or oversight if we become subject … or proprietary information, we could incur liability and reputational damage and the further development and future commercialization of our current
10-Q
2023 Q2
TSBX
Turnstone Biologics Corp.
1 Sep 23
Quarterly report
4:39pm
of confidential or proprietary information, we could incur liability and reputational damage and the further development and future commercialization … , business and reputational harm to us. For example, any such event that leads to unauthorized access, use, or disclosure of personal information
424B4
gp1f0n7oci2
21 Jul 23
Prospectus supplement with pricing info
7:14pm
S-1/A
964uj0y8v5 8bij
23 Jun 23
IPO registration (amended)
9:49pm
S-1
v1k56n1
12 Jun 23
IPO registration
4:28pm
DRS
ilbv21w
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next